Category: 8. Health

  • System built for disease early warning

    System built for disease early warning

    China has established a four-tier risk assessment system to enhance the nation”s early warning capabilities for infectious diseases, according to a guideline released by the National Disease Control and Prevention Administration recently.

    The trial regulation, which takes effect immediately, aims to tackle public health risks caused by various infectious diseases, including the nation’s 41 notifiable diseases, novel infectious illnesses and those with unknown causes.

    Under the guideline, local disease control agencies are required to collect infectious disease monitoring information from multiple sources and carry out risk evaluations. The risk levels are classified into four tiers from extremely low risk to high risk.

    An extremely low risk assessment only requires continuous implementation of regular monitoring, while a low-risk evaluation should prompt the release of health risk advisories to the public.

    “A health risk advisory is supposed to include pathogenic and epidemic characteristics of the disease, typical clinical symptoms, recent monitoring results, key control and preventive measures,” it said. “Such an advisory should be scientific, clear, easy to understand and capable of being disseminated through various channels.”

    With a medium-risk assessment, medical institutions and other related departments should take professional precautionary measures. Disease control authorities will consider issuing a warning, which is meant to be circulated across related government departments and healthcare institutions.

    A warning will include information about the hazards of the disease, the range of affected areas, development trends and suggestions on personnel technical training, supplies preparation, case identification and reporting procedures, ventilation and disinfection at key venues and other preventive measures, the guideline said.

    With a high-risk evaluation, disease control agencies should make reports to disease control authorities within two hours, who in turn will gather experts to further analyze and evaluate the severity of epidemic risk and determine if an alert should be issued by the regional government.

    The guideline also requests encouraging and supporting the use of digital technologies to define warning thresholds, as well as calls for the establishment of an epidemic database and related algorithm model libraries to build a multi-trigger and smart early warning system.

    It stresses providing necessary personnel, funding, equipment, infrastructure and policy support, as well as strengthening cross-department cooperation to facilitate early warning operations.

    “The early warning information should be clear, accurate, authoritative and professional, and pay attention to protecting personal privacy,” it added.

    China aims to build a highly-efficient infectious early warning mechanism featuring multi-trigger points and swift dissemination by 2030, positioning itself among world-leading ranks in the field of early detection, scientific assessment and prompt early warning of epidemics.

    According to Lei Zhenglong, an official at the administration, China has carried out surveillance for the novel coronavirus, influenza and other acute respiratory diseases at 1,041 sentinel hospitals, covering all municipal-level regions and key counties.

    Meanwhile, various monitoring channels, including vector organisms, urban sewage, global trends and public opinions, have been used to improve the sensitivity and accuracy of monitoring.

    The central finance also invested funds in 2023 and 2024 to support the establishment of provincial-level information platforms, with Beijing, Tianjin and the provinces of Hubei and Zhejiang having completed initial construction.

    As of the end of last year, about 71 percent of secondary or tertiary public hospitals had been equipped with smart surveillance and early warning software as part of efforts to use novel technologies to improve analysis and assessments of epidemic data, Lei said.

    Continue Reading

  • Polyphenols and exercise show promise in fighting gliomas

    Polyphenols and exercise show promise in fighting gliomas

    Scientists reveal how plant-based compounds and targeted workouts could work together to protect the brain, slow tumor progression, and improve life for people with gliomas.

    Review: Polyphenol-Based Nutritional Strategies Combined With Exercise for Brain Function and Glioma Control: Focus on Epigenetic Modifications, Cognitive Function, Learning and Memory Processes. Image Credit: Lightspring / Shutterstock

    In a recent review published in the journal Food Science & Nutrition, researchers synthesized evidence on how dietary polyphenols combined with exercise influence epigenetic regulation, cognition, and glioma control, outlining practical applications.

    Background

    One in two people will face a brain-health challenge over their lifetime, through aging, stress, or disease, and for many, the blow lands on attention, memory, and mood. Gliomas, the most common primary tumors of the central nervous system (CNS), add a harsh edge: seizures, fatigue, and thinking changes that disrupt work and family life. Diet and movement are two levers within control. Plant polyphenols in tea, berries, and turmeric ease inflammation and oxidative stress; exercise builds brain resilience and quality of life. Emerging research hints that these tools work better together through epigenetic pathways. Further research must define who benefits, when, and how.

    How Glioma Shapes Patient Lives

    Gliomas are the most common primary tumors of the CNS. Modern classification goes beyond World Health Organization (WHO) histology by integrating molecular markers that forecast response and survival. Two standouts are isocitrate dehydrogenase (IDH) mutation and combined loss of chromosomal arms 1p/19q (codeletion).

    IDH mutations generate the oncometabolite 2-hydroxyglutarate, trigger wide epigenetic reprogramming, and are early events that generally predict better progression-free survival than wild-type disease. In contrast, IDH-wild-type glioblastoma often has a poorer outlook.

    Telomerase reverse transcriptase (TERT) promoter mutations, together with IDH status and 1p/19q codeletion, further refine prognosis. “Triple-positive” lower-grade tumors tend to fare best, while tumors with only TERT mutations correlate with poor prognosis, especially in the absence of MGMT promoter methylation.

    Meanwhile, O6-methylguanine-deoxyribonucleic acid methyltransferase (MGMT) promoter methylation predicts sensitivity to the alkylating agent temozolomide. These features explain why two people with the same histology can face very different journeys.

    Why Pair Polyphenols with Exercise?

    Dietary polyphenols, such as curcumin, resveratrol, quercetin, and epigallocatechin gallate (EGCG), modulate deoxyribonucleic acid (DNA) methylation, histone marks, and noncoding ribonucleic acid (RNA), shifting gene programs linked to neurogenesis, synaptic plasticity, and gliomagenesis.

    Quercetin and curcumin face significant bioavailability challenges, requiring nano-formulations or absorption enhancers like piperine for clinical efficacy. Exercise induces its own epigenetic remodeling, improves mitochondrial function, and up-regulates brain-derived neurotrophic factor (BDNF), a master switch for learning and memory.

    Converging on these pathways, polyphenols and exercise together offer a plausible, non-pharmacological route to enhance cognition and restrain tumor signaling by restoring tumor-suppressor activity and attenuating oncogenic pathways; however, these synergies remain largely theoretical and preclinical. Put simply, food chemicals and movement nudge the same molecular dimmers that help brains learn, and tumors slow down.

    Role of physical activity in cancer prevention and therapy. Engaging in regular physical exercise offers significant benefits in both the prevention and treatment of cancer. For individuals affected by cancer, exercise contributes in three major ways: It reduces the likelihood of developing cancer, enhances the effectiveness of therapeutic interventions, and alleviates many of the adverse side effects associated with treatment. Mechanistically, the anticancer effects of physical activity are primarily attributed to its ability to inhibit tumor cell proliferation, induce programmed cell death (apoptosis), regulate tumor-related metabolic pathways, and enhance immune system function.Role of physical activity in cancer prevention and therapy. Engaging in regular physical exercise offers significant benefits in both the prevention and treatment of cancer. For individuals affected by cancer, exercise contributes in three major ways: It reduces the likelihood of developing cancer, enhances the effectiveness of therapeutic interventions, and alleviates many of the adverse side effects associated with treatment. Mechanistically, the anticancer effects of physical activity are primarily attributed to its ability to inhibit tumor cell proliferation, induce programmed cell death (apoptosis), regulate tumor-related metabolic pathways, and enhance immune system function.

    What Exercise Adds

    Across ages, regular aerobic training improves executive function, memory, and mood; neuroimaging shows larger hippocampal volume and better cerebral blood flow. Resistance training at moderate-to-high intensity enhances visuospatial skills and working memory, likely via insulin-like growth factor-1 signaling and improved prefrontal perfusion.

    Findings for combined (concurrent) programs are mixed but show significant cognitive improvements when integrated with cognitive tasks (e.g., dual-task training). Meta-analyses indicate moderate-duration, moderate-frequency programs can meaningfully increase global cognition, with pronounced effects in clinical and older populations.

    Practical takeaways: moderate-intensity aerobic activity (e.g., brisk walking or cycling) 2–3 times per week for at least 30 minutes supports memory and executive function; resistance training two to three times weekly similarly aids cognitive performance and brain plasticity. These gains translate into real-life benefits, such as safer mobility, smoother medication management, and confidence to return to work or study.

    Polyphenols as Epigenetic Signal Shapers

    Resveratrol exerts antioxidant, anti-inflammatory, and neuroprotective actions and, in preclinical models, protects neurons from amyloid-beta toxicity; anthocyanin-rich blueberries have been linked with memory benefits in older adults. Curcumin can influence histone acetylation and DNA methylation by inhibiting histone deacetylases and DNA methyltransferases.

    The practical challenge is bioavailability. Combining curcumin with piperine or using nanoparticle formulations (e.g., nanocurcumin at 80 mg/kg in rodent studies, a dose from cited preclinical work, not a clinical recommendation) improves absorption and may enhance brain and tumor-microenvironment effects.

    Together, such compounds are positioned to tune gene expression toward synaptic resilience while damping inflammatory and proliferative signaling relevant to glioma biology.

    Where Diet Meets Movement

    Mechanistically, both levers meet at epigenetic control points and inflammatory tone. Polyphenols can help restore tumor-suppressor gene activity and temper oncogenic signaling; exercise raises BDNF, enhances neuroplasticity, and remodels chromatin in learning-and-memory networks.

    The integrated model predicts additive or even synergistic gains: clearer thinking and stronger memory through shared neurotrophic and chromatin effects, and a less permissive tumor microenvironment through stress-response and metabolic rebalancing, though these mechanisms are hypothesized and require clinical validation.

    To test this rigorously, the field needs trials that pair specific polyphenols (for example, resveratrol, curcumin, or EGCG) with defined aerobic, resistance, or combined protocols; track cognition and tumor control; and embed epigenomic profiling to identify responders and optimal dose, timing, and formulation.

    Personalization, Timing, and Feasibility in the Real World

    Two pragmatic details help translation. First, timing: cognitive performance and training responses follow circadian rhythms. Aligning sessions with a person’s chronotype, often late-afternoon or early-evening peaks, can amplify benefits, while guarding sleep from late-night blue light (which disrupts melatonin and impairs next-day cognition) preserves next-day cognition.

    Second, tailoring: dose, timing, and formulation govern polyphenol bioavailability; pairing intake with meals and using absorption enhancers where appropriate can matter.

    Finally, programs should meet people where they are: prioritizing short, frequent bouts; home-based options; and professional supervision for those with fatigue or balance issues, recognizing that consistency and safety are critical in glioma patients.

    Conclusions

    This review concludes that lifestyle can function as an adjunct therapy for CNS tumors: polyphenol-rich nutrition plus structured exercise acts on epigenetic and neurotrophic pathways. Together, they modulate DNA/RNA programs, elevate BDNF, and render the glioma microenvironment less permissive. Heterogeneity across IDH status, MGMT promoter methylation, 1p/19q codeletion, and TERT promoter alterations implies variable responses, making personalization essential.

    Future trials should standardize exercise dose, specify polyphenol type/formulation (e.g., EGCG or nanocurcumin), and integrate epigenomic and clinical outcomes. If validated, this dual strategy could convert everyday choices into measurable gains in memory, independence, and quality of life for people living with glioma. However, current evidence for combined polyphenol-exercise benefits remains preclinical.

    Journal reference:

    • Yang, G., W. Yang, & F. Kiarasi. (2025). Polyphenol-Based Nutritional Strategies Combined With Exercise for Brain Function and Glioma Control: Focus on Epigenetic Modifications, Cognitive Function, Learning and Memory Processes. Food Science & Nutrition. 13(8). DOI: 10.1002/fsn3.70758, https://onlinelibrary.wiley.com/doi/10.1002/fsn3.70758

    Continue Reading

  • New Protein Therapy Shows Promise as First-Ever Antidote for Carbon Monoxide Poisoning

    New Protein Therapy Shows Promise as First-Ever Antidote for Carbon Monoxide Poisoning

    Newswise — University of Maryland School of Medicine (UMSOM) researchers, along with their colleagues, engineered a new molecule that appears promising as an effective antidote for carbon monoxide poisoning with fewer side effects than other molecules currently being tested, according to a new study published in the journal PNAS.

    Carbon monoxide poisoning accounts for 50,000 emergency room visits in the U.S. each year and causes about 1,500 deaths. These deaths may occur when carbon monoxide released from combustion builds up in an enclosed space, which can result from ventilation failures in indoor natural gas burning equipment, or running gasoline generators or automobiles indoors or in a closed garage. Carbon monoxide poisoning is also associated with most fires from smoke inhalation.

    Currently, the only treatments for carbon monoxide poisoning are oxygen-based therapies, which help the body eliminate the toxic gas. However, even with treatment, nearly half of survivors suffer long-term heart and brain damage. This has created an urgent need for faster, more effective therapies.

    In the new study, the research team developed a new engineered protein-based therapy called RcoM-HBD-CCC, which acts like a sponge to soak up carbon monoxide from the blood. Beginning with RcoM (short for “regulator of metabolism”)—a natural protein the bacterium Paraburkholderia xenovorans uses to sense minute levels of carbon monoxide—the researchers engineered a version that is highly selective: It grabs carbon monoxide without interfering with oxygen or other important molecules in the body.

    In tests on mice, the new therapy worked quickly to remove carbon monoxide from red blood cells and was safely flushed out of the body through urine. “Unlike other protein-based treatments, we found the compound caused only minimal changes in blood pressure, which was an exciting finding and raised the potential for this new molecule to have clinical applications,” said study corresponding author Mark T. Gladwin, MD, Dean of UMSOM who is also the Vice President for Medical Affairs, University of Maryland, Baltimore (UMB), and the John Z. and Akiko K. Bowers Distinguished Professor. “This has the potential to become a rapid, intravenous antidote for carbon monoxide that could be given in the emergency department or even in the field by first-responders.”

    How Carbon Monoxide Kills

    In healthy bodies, oxygen inhaled from the air binds to the protein hemoglobin on the surface of red blood cells, which then ferry the oxygen to all the tissues of the body. Inhaled poisonous carbon monoxide gas, however, competes with oxygen for hemoglobin. It enters the bloodstream and binds to hemoglobin with a 200 to 400-fold greater affinity than oxygen. That means carbon monoxide hogs most of the hemoglobin seats, so not enough oxygen molecules can get a ride to the tissues that need them.

    Currently, the only available treatments for carbon monoxide poisoning involve giving 100 percent pure oxygen, sometimes under pressure in a hyperbaric chamber.

    All too often, patients are not transported, diagnosed, and treated in time to reverse the effects of carbon monoxide poisoning, which can cause lasting cardiac and neurological injuries or even death.

    “This molecule could be a game-changer because it can directly and rapidly remove carbon monoxide from the body with such a low risk of off-target side effects,” said Jason J. Rose, MD, MBA, Associate Professor of Medicine, Division Chief of Pulmonary, Critical Care & Sleep Medicine, and one of the study’s researchers. “Given the promising results, we also see the potential for RcoM-HBD-CCC use in other areas, like as a blood substitute in severe anemia or hemorrhagic shock.”

    Bloodstream Scavengers

    The research team focused on engineering carbon monoxide “scavengers,” which are proteins structurally similar to hemoglobin, known as hemoproteins, but exhibiting even greater binding affinity — stickiness — for carbon monoxide, and less affinity for binding oxygen.

    Infused in the bloodstream, scavenger hemoproteins like RcoM-HBD-CCC rapidly bind to carbon monoxide molecules, reducing the time it takes to clear half of the carbon monoxide in the blood to less than a minute, compared to more than hour with pure oxygen therapy and five hours without any treatment. When carbon monoxide is cleared, this frees hemoglobin on red blood cells to begin carrying oxygen once again.

    But many hemoproteins also share some affinity for binding oxygen, and can therefore also scavenge nitric oxide, a molecule important in regulating blood pressure. Infusions of hemoproteins or hemoglobin can reduce the levels of nitric oxide in the blood, leading to tightened blood vessels and a rapid rise in blood pressure. 

    In this latest study, the researchers were surprised to find that RcoM-HBD-CCC did not result in an increase in blood pressure regardless of whether carbon monoxide was present in the blood. They theorize that while RcoM-HBD-CCC may scavenge nitric oxide, a blood-pressure regulating molecule, it may do so more slowly than other hemoproteins, leading to its safer profile.

    Future studies will likely include more pre-clinical research to determine the safe and effective dosage range for RcoM-HBD-CCC in treating carbon monoxide poisoning. It could also form the basis for new research in other fields, including as an oxygen delivery therapy or blood substitute. This could include hemorrhagic shock, acute respiratory distress syndrome (ARDS), severe anemias, and the preservation of organs for transplantation.

    Dr. Rose and Dean Gladwin are co-founders and directors of Globin Solutions, which has licensed technology based on RcoM from the University of Pittsburgh towards the development of a CO poisoning antidote. Dr Rose is President and CEO of Globin Solutions. Globin Solutions has sponsored research agreements with UMB.

    About the University of Maryland School of Medicine

    The University of Maryland School of Medicine, established in 1807 as the first public medical school in the U.S., continues today as one of the fastest growing, top-tier biomedical research enterprises in the world. The School has nearly $500 million total research funding, 46 departments, centers, and institutes, more than 2,200 student trainees and over 3,000 faculty members, including notable members of the National Academy of Medicine.  As the largest public medical school in the DC/MD/VA region, faculty-physicians are working to help patients manage chronic diseases like obesity, cancer, heart disease and addiction, while also working on cutting-edge research to address the most critical generational health challenges. In 2024, the School ranked #12 among public medical schools and #27 among all medical schools for R&D expenditures by the National Science Foundation. With a $1.3 billion total operating budget, the School partners with the University of Maryland Medical Center to serve nearly 2 million patients annually. The School’s global reach extends around the world with research and treatment facilities in 33 countries. In Maryland, the School of Medicine is spearheading new initiatives in AI and health computing and partnering with the University of Maryland BioPark to develop new medical technologies and bioengineering ventures. For more information, visit medschool.umaryland.edu. 


    Continue Reading

  • NAPPRS: Dead animal disposal practices on sow farms

    NAPPRS: Dead animal disposal practices on sow farms

    Procedures for dead animal removal need to be specific yet adaptable


    13 August 2025

    clock icon
    3 minute read

    Pigs on sow farms often die from various causes, including contagious diseases. An association between using rendering for dead animal disposal and higher risk or porcine reproductive and respiratory syndrome virus (PRRSV) outbreaks has been reported in the literature. However, a detailed characterization of disposal practices and facilities used in the US is needed to understand and mitigate associated risks.

    A study by I.A.D. Paploski and colleagues at the University of Minnesota, USA, aimed to characterize the facilities, structures and procedures for dead animal disposal on sow farms, as well as test if environmental samples collected in and around dead animal disposal structures contain detectable quantities of PRRSV and porcine epidemic diarrhea virus (PEDV). The results of the study were presented at the 2024 North American PRRS Symposium.

    Ten standard operating procedures (SOPs) from different systems were obtained. Data from SOPs were categorized into sections: biosecurity, dead animal gathering space in the barn, removal from the barn, transport out of the barn, and final destination and used to create a questionnaire for on-site visits. Five farms with 2,000 to 5,000 sows on each from three systems were visited to apply the questionnaire and collect environmental samples for PRRSV and PEDV testing.

    The SOPs varied significantly in detail, with the most comprehensive being 12 pages and the shortest having only 1 page containing 11 lines. Biosecurity measures were generally outlined but inconsistent, particularly regarding personnel roles. Dead animal gathering spaces were mentioned in most SOPs, often cleaned and disinfected, but methods varied.

    Dead sow removal methods were usually detailed, while dead piglet removal and afterbirth were less consistently addressed. Transport methods of carcasses between the barn and the compost pile or rendering truck pick up site were done primarily using tractors or pickups and were cited in most SOPs, but cleaning protocols were often not mentioned.

    Final disposal destinations were inconsistently mentioned. Farm visits revealed that dead animal removal was typically the last task of the day, regardless of PRRS status. Environmental conditions, especially wind direction, can be important if removal happens daily. Wildlife exposure to disposal areas was commonly reported.

    Three finisher sites (all PRRSV positive, one PEDV positive) were visited and a total of 25 environmental samples were collected from roads, machines and structures involved in moving dead animals. All samples from one farm tested negative for PRRSV and PEDV by RT-PCR. From the remaining two farms, a total of 12 and 5 samples tested RT-PCR positive for PRRSV-2 and PEDV, respectively. Positive samples were found on dead animals, rendering boxes, skid loader buckets and nearby ground. One PRRSV isolate was obtained from a sample collected on the ground, while no viable PEDV was isolated.

    Creating SOPs for dead animal removal on farms is challenging due to the need for specific yet adaptable instructions. SOPs should include detailed biosecurity protocols, procedures for removing dead animals and cleaning and disinfection guidelines.

    This study shows that samples collected from or near rendering boxes can test positive for farm-specific viruses and may contain viable viruses. Positive samples on roads suggest potential PRRSV transmission pathways between farms. Further studies on different disposal methods, such as composting or incineration, are warranted to ensure effective biocontainment of viruses on farms.


    Continue Reading

  • The Easiest High-Fiber Swap to Help You Poop

    The Easiest High-Fiber Swap to Help You Poop

    • The easiest high-fiber swap to help you poop is swapping popcorn in place of chips.
    • Popcorn is a whole grain that boasts fiber and antioxidants and is low in saturated fat and sugar.
    • Dietitians say regular exercise, mindful eating and proper hydration are keys to better digestion.

    Struggling to go No. 2? You’re not alone. In fact, the National Institute for Diabetes and Digestive and Kidney Diseases estimates that around 16% of the adult population struggles with constipation daily. The good news is there are proactive things you can do to ease your constipation woes without spending a fortune. 

    Enter—simple food swaps! No, we’re not suggesting swapping cauliflower pizza crust for the real deal (though don’t knock that one until you try it). Rather, we’re encouraging you to explore the better-for-you alternatives for common snacks that pack a bit more nutritional bang per bite. Dietitians say the easiest high-fiber swap to help you poop is choosing air-popped popcorn in place of potato chips. 

    Why Air-Popped Popcorn Is the #1 Swap

    It’s High In Fiber 

    Fiber is a key component of a diet that promotes regular bowel movements, and unfortunately, most Americans are falling short on eating enough of this nutrient. High sources of dietary fiber positively impact metabolic health and the microbiome. You see, popcorn contains resistant starch and serves as a prebiotic, providing food for the good gut bugs in your gut that keep your digestive system running smooth., Gut-health nutrition expert Jessie Wong, MAcc, RDN, LD, is also a popcorn advocate, sharing, “Popcorn is a whole-grain snack packed with insoluble fiber, which adds bulk to stool and helps food move more efficiently through the digestive tract. This promotes regularity and supports overall bowel health.” 

    The best part—swapping 1-ounce of popcorn in place of 1-ounce of chips provides 3 additional grams of dietary fiber, inching you closer to the recommended 25 to 38 grams of fiber per day.,

    It’s a Whole Grain 

    The 2020-2025 Dietary Guidelines for Americans recommend consuming at least 50% of your grains from whole grains sources. Whole grains contain the entire bran layer of the grain kernel, meaning they pack more fiber and other nutrients that other refined grains lack. In fact, dietitian Roxana Ehsani, MS, RD, CSSD, shares, “One serving of popcorn provides one-third of your daily whole grain needs, and 4 grams of dietary fiber.” Wong points out eating more whole grains routinely helps nourish your microbiome, “contributing to more predictable bowel movements.” 

    It’s Filled with Polyphenols 

    Popcorn contains compounds known as polyphenols, which have antioxidant properties. Antioxidants help protect cells from damage caused by free radicals–the “bad guys” that may cause harm to our health in the long run. Research has explored the health benefits of popcorn throughout the decades, concluding it has a positive influence on gut health thanks to its polyphenol activity specifically. Ehsani shares, “Popcorn’s polyphenols can help reduce inflammation in the gut and support the growth of healthy gut bacteria. A healthy gut microbiome results in better digestion and more regular bowel movements.”

    It’s Low in Saturated Fat & Sugar 

    The high fiber content of air-popped popcorn helps fill you up while delivering important vitamins and minerals with no saturated fat or added sugar. Research shows that people who struggle with constipation may have poor diet quality, such as high intakes of saturated fat and added sugar. Replacing foods high in these with better-for-you options, like popcorn or other high fiber foods, provides support for your microbiome and can ease constipation while promoting better digestion. Wong shares, “Air-popped popcorn is low in calories, but high in volume, providing a satisfying crunch and fullness without the heavy fats or additives often found in chips, making it a gut-friendly choice for snacking.”

    Strategies for Better Digestion

    Better gut health is possible, but it involves taking a close look at both diet and lifestyle.  Wong shares, “Bowel health isn’t just about eating more fiber — it’s about the whole picture. Managing stress, getting enough sleep, and listening to your body’s natural cues are just as important as what’s on your plate.” Consider these dietitian-recommended tips for better digestion too.

    • Move Your Body: Regular exercise is essential for better bowel health. Wong and Ehsani recommend consistent daily movement in whatever form feels enjoyable. Pick your favorite–a short walk, resistance exercise, or a swim all count. 
    • Stay Hydrated: Drinking water throughout your day helps prevent dehydration, a common culprit in struggling to go number 2. Carry a large reusable water and make a goal to refill it with every mealtime, ensuring you’re constantly drinking throughout your day. 
    • Eat probiotic rich foods: Probiotics help nourish a healthy gut and aid digestion, helping to keep your bowel movements regular. Consider adding more probiotic rich foods into your diet, like kefir, yogurt, sauerkraut, kimchi, or kombucha.
    • Slow down. Being mindful as you eat is important, notes Braddock, as quickly consuming large volumes of food can disrupt your digestion. Consider taking some deep breaths before eating to help calm your nervous system and prepare to properly digest. 
    • And yes, eat more fiber. Braddock recommends eating more high-fiber fruits and veggies routinely to find relief. She writes, “Raspberries are one of the highest fiber fruits per serving. Plus, eating two kiwis a day can help improve constipation and abdominal discomfort.”

    Meal Plan to Try

    Simple 7-Day Meal Plan to Help You Poop, Created by a Dietitian

    Our Expert Take 

    Smart foods swaps can help improve your gut health—in turn offering relief from constipation that may be weighing you down. While fruits and vegetables are natural choices to swap in for other less nutritious choices, they don’t always satisfy you the same way. That’s why nutrition experts recommend starting small with easy swaps that may be more satisfying, like trying air-popped popcorn in lieu of potato chips to get that same crunch with more fiber and antioxidants. Fiber is a key component to helping you poop, and every gram counts! Consider making a bowl of our EatingWell reader favorite, Cinnamon Popcorn, to nosh on when hunger strikes.

    Continue Reading

  • High-potassium diets show consistent mental health benefits

    High-potassium diets show consistent mental health benefits

    From kimchi to leafy greens, scientists uncover how mineral-rich diets, especially potassium, may help protect mental health across cultures.

    Study: Mineral Intake and Depression: A Cross-Sectional Comparative Study Based on National Health and Nutrition Examination Surveys in Korea and the United States. Image Credit: Yulia Furman / Shutterstock

    In a recent article published in the journal Nutrients, researchers investigated the relationship between the intake of minerals such as calcium, zinc, and iron, and the incidence of depression among adults in the United States and Korea.

    They found that Korean adults with higher intakes of potassium and sodium were less likely to experience depression, with phosphorus showing a borderline association, a finding similar to that of American adults with higher intakes of potassium and zinc, with iron showing borderline significance.

    Background

    Depression is a widespread mood disorder marked by persistent sadness and hopelessness, and is expected to become a major global health burden. In South Korea, about 5% of adults report depressive disorders, while in the U.S., over 17 million adults experience at least one major depressive episode each year.

    Many affected individuals remain untreated, often due to stigma and reluctance to seek help, while high recurrence rates make management challenging. Nutrition has been increasingly linked to mental health, with deficiencies in minerals such as magnesium, zinc, and selenium associated with cognitive decline and psychiatric conditions.

    However, the roles of sodium and potassium in depression have received little attention, despite their abundance in everyday diets. Sodium is mainly consumed as table salt, while potassium is found in a variety of foods.

    Given the limited research and the potential for dietary guidance to improve mental health outcomes, this study aimed to comprehensively assess the association between seven dietary minerals and depression in Korean and American adults.

    The comparison between these two culturally and nutritionally distinct populations could help identify shared and unique patterns, offering a foundation for future research and public health strategies in mental health nutrition.

    About the Study

    In this cross-sectional analysis, researchers utilized data from nationally representative health and nutrition surveys in both countries, employing multistage, stratified sampling. Korean adults aged 19 and above and American adults aged 18 and above who completed depression screening were included, excluding those who were pregnant, under depression treatment, or with missing key data.

    The final sample included 12,996 Koreans and 9,547 Americans. People with a depression score of 10 or over were considered to be depressed. Dietary mineral intake (calcium, zinc, iron, magnesium, phosphorus, sodium, and potassium) was estimated from 24-hour dietary recalls, using national food composition databases.

    Covariates included demographics, socioeconomic factors, body mass index (BMI), lifestyle habits, comorbidities, and total energy intake. Associations between mineral intake and depression were assessed using multivariable logistic regression, adjusting for potential confounders. Survey-specific sampling weights ensured national representativeness.

    Key Findings

    In the Korean sample, 4.1% of 12,996 participants had depression, while in the American sample, 6.2% of 9,547 participants were affected.

    In both countries, individuals with depression were more often female, had lower income and education levels, were more likely to live alone, and showed higher depression screening scores, smoking rates, diabetes prevalence, and comorbidity scores.

    Regular exercise was less common in the U.S. depression group. Mineral intake was generally lower among those with depression, except for calcium, which did not follow this pattern.

    Multivariable-adjusted analyses showed that in Korea, higher sodium and potassium intakes were significantly associated with lower odds of depression, with phosphorus showing borderline significance.

    In the U.S., potassium and zinc were significantly associated, and iron showed borderline significance. Restricted cubic spline analysis indicated that intakes below certain thresholds were linked to higher depression risk.

    Subgroup analysis revealed population- and group-specific patterns: for example, sodium was protective among Korean men, potassium among older Americans, and zinc among non-obese Americans. Additional subgroup findings included significant associations for phosphorus among Korean females, potassium, iron, and zinc among U.S. males, and sodium among Koreans aged ≤65 years.

    Some minerals were associated with depression in one sex or BMI category but not the other. Potassium was the only mineral consistently linked to lower depression risk in both countries, highlighting its potential universal relevance for mental health. Notably, magnesium and calcium showed no significant associations with depression in either population.

    Conclusions

    This study found inverse associations between certain minerals and depression, with patterns differing between Korea and the U.S. Potassium consistently showed protective effects in both populations, while sodium was significant in Korea, phosphorus showed borderline significance in Korea, and iron showed borderline significance, and zinc was substantial in the U.S.

    These differences may reflect variations in average intake, dietary sources, and nutrient bioavailability, such as substantially higher sodium intake in Korea from fermented vegetables, soups, and stews, or greater bioavailable heme iron and zinc from red meat in the U.S.. In contrast, Korean diets feature more plant-based and seafood sources with lower nutrient bioavailability.

    Strengths include large, nationally representative datasets from two culturally distinct countries, the examination of seven minerals, and subgroup analyses revealing demographic and lifestyle influences.

    Limitations involve the cross-sectional design, preventing causal inference, possible reverse causation, reliance on 24-hour recall, which may be particularly inaccurate, especially due to depression-related memory impairment, and the use of self-reported depression measures that can be subject to bias.

    Overall, the findings suggest that dietary mineral intake could be integrated into mental health strategies. Longitudinal studies are needed to confirm causality and clarify mechanisms linking minerals to depression risk.

    Journal reference:

    • Mineral Intake and Depression: A Cross-Sectional Comparative Study Based on National Health and Nutrition Examination Surveys in Korea and the United States. Kim, J., Kim, I., Lee, J., Jeon, K., Kang, J., Lee, D., Choi, S., Kim, H.S., Son, M. Nutrients (2025). DOI: 10.3390/nu17162593 https://www.mdpi.com/2072-6643/17/16/2593

    Continue Reading

  • Cats’ Brains and Alzheimer’s Disease: PETA Statement on New Study – PETA

    1. Cats’ Brains and Alzheimer’s Disease: PETA Statement on New Study  PETA
    2. Feline Dementia Mirrors Human Alzheimer’s  Neuroscience News
    3. Cats with dementia show brain changes similar to Alzheimer’s in humans  News-Medical
    4. Cats Show Alzheimer’s Changes; MS Lesions Start Early; Contested Paper Retracted  MedPage Today
    5. Cats develop dementia similarly to humans – study  MSN

    Continue Reading

  • Colorado rabbits spotted with scary ‘horns and tentacles’ on their head; experts warn locals of growth virus

    Colorado rabbits spotted with scary ‘horns and tentacles’ on their head; experts warn locals of growth virus

    Residents in Fort Collins and other parts of Colorado have spotted wild rabbits with ‘scary’ horn-like and tentacle-shaped growths protruding from their heads and faces. Photos circulating on social media have startled locals. They show the animals with black, spiny structures resembling toothpicks or quills, sparking alarm and speculation about possible diseases.

    Colorado residents have spotted several rabbits with tentacle-like growth(X)

    Wildlife experts revealed that the unsettling condition is caused by Shope papilloma virus, a disease that creates wart-like tumors on rabbits, often around the head, ears, and eyelids. While the growths may look disturbing, officials stressed they do not pose a threat to humans, pets, or other wildlife.

    The virus only spreads between rabbits, typically through bites from insects such as mosquitoes and ticks. According to the University of Missouri, the condition is a DNA virus ‘seen most frequently in cottontail rabbits of the Midwest with outbreaks in domestic rabbits’.

    Local Sightings and reactions

    Fort Collins residents have reported multiple sightings, including one rabbit that returned to a homeowner’s yard for two consecutive years with increasingly severe growths.

    Some residents initially feared the animals had plague or another dangerous illness.

    Descriptions of the appearance range from ‘black quills’ to a ‘scabby growth’ covering parts of the face.

    “I thought he would die off during the winter, but he didn’t,” a local, Susan Mansfield, told NBC local affiliate KUSA.“He came back a second year, and it grew.”

    What is Shope Papilloma Virus?

    The virus causes benign wart-like tumors, but in some cases, these can become malignant (cancerous). While generally not harmful to the rabbit’s overall health, tumors can create problems if they obstruct the mouth, nose, or eyes.

    The disease is relatively common in wild rabbit populations, particularly during warmer months when insect activity is high.

    There is no known cure for the virus; surgical removal of tumors is sometimes performed for domestic rabbits.

    Colorado Parks and Wildlife is advising residents to keep their distance. The rabbits are not dangerous.

    Continue Reading

  • Study reveals gait retraining could help treat knee osteoarthritis

    Study reveals gait retraining could help treat knee osteoarthritis

    Editor’s note: This article was adapted from a release from the University of Utah.

    Nearly a quarter of people over the age of 40 experience painful osteoarthritis, making it a leading cause of disability in adults. Osteoarthritis involves degradation of joint-cushioning cartilage, and there is currently no way of reversing this damage: the only option is to manage pain with medication, and eventually, joint replacement. 

    A study conducted at Stanford University is now demonstrating the potential for another option: gait retraining. 

    By making a small adjustment to the angle of their foot while walking, participants in a year-long randomized control trial experienced pain relief equivalent to medication. Critically, those participants also showed less knee cartilage degradation over that period as compared to a group that received a placebo treatment.

    Published in The Lancet Rheumatology, it is the first placebo-controlled study to demonstrate the potential effectiveness of a biomechanical intervention for osteoarthritis. 

    The study was led by an interdisciplinary team at Stanford: Scott Uhlrich, who is now an assistant professor in the John and Marcia Price College of Engineering’s Department of Mechanical Engineering at the University of Utah; Valentina Mazzoli, who is now an assistant professor in New York University’s Department of Radiology; and Julie Kolesar, a research engineer in Stanford’s Human Performance Lab who worked for the Veteran’s Administration at the time of the study. 

    “We’ve known that for people with osteoarthritis, higher loads in their knee accelerate progression, and that changing the foot angle can reduce knee load,” said Uhlrich. “So the idea of a biomechanical intervention is not new, but there have not been randomized, placebo-controlled studies to show that they’re effective.” 

    A personalized approach 

    The researchers were specifically looking at patients with mild-to-moderate osteoarthritis in the medial compartment of the knee – on the inside of the leg – which tends to bear more weight than the lateral, outside, compartment. This form of osteoarthritis is the most common, but the ideal foot angle for reducing load in the medial side of the knee differs from person to person depending on their natural gait and how it changes when they adopt the new walking pattern. 

    “Previous trials prescribed the same intervention to all individuals, resulting in some individuals not reducing, or even increasing, their joint loading,” said Uhlrich. “We used a personalized approach to selecting each individual’s new walking pattern, which improved how much individuals could offload their knee and likely contributed to the positive effect on pain and cartilage that we saw.” 

    “This study not only demonstrates a promising approach to help individuals with osteoarthritis,” said Scott Delp, a senior author of the paper, director of the Wu Tsai Human Performance Alliance at Stanford, and James H. Clark Professor in the School of Engineering, “It also showcases how powerful a more personalized approach can be.”

    Scott Delp | Andrew Brodhead

    In their first two visits, participants received a baseline MRI and practiced walking on a pressure-sensitive treadmill while motion-capture cameras recorded the mechanics of their gait. This allowed the researchers to determine whether turning the patient’s toe inward or outward would reduce load more, and whether a 5- or 10-degree adjustment would be ideal.

    This personalized analysis also screened out potential participants who could not benefit from the intervention, as none of the foot angle changes could decrease loading in their knees. These participants were included in previous studies, which may have contributed to those studies’ inconclusive pain results. 

    Moreover, after their initial intake sessions, half of the 68 participants were assigned to a sham treatment group to control for the placebo effect. These participants were prescribed foot angles that were identical to their natural gait. Conversely, participants in the intervention group were prescribed the change in foot angle that maximally reduced their knee loading. 

    Participants from both groups returned to the lab for six weekly training sessions, where they received biofeedback – vibrations from a device worn on the shin – that helped them maintain the prescribed foot angle while walking on the lab’s treadmill. After the six-week training period, participants were encouraged to practice their new gait for at least 20 minutes a day, to the point where it became natural. Periodic check-in visits showed that participants were adhering to their prescribed foot angle within a degree on average. 

    After a year, all participants self-reported their experience of knee pain and had a second MRI to quantitatively assess the damage to their knee cartilage. 

    “The reported decrease in pain over the placebo group was somewhere between what you’d expect from an over-the-counter medication, like ibuprofen, and a narcotic, like OxyContin,” Uhlrich said. 

    Delp added, “The MRIs also showed improved biomarkers of cartilage health in the intervention group. This is an exciting finding that gives hope to people with osteoarthritis.” 

    A lasting intervention 

    Beyond the quantitative measures of effectiveness, participants in the study expressed enthusiasm for both the approach and the results. One participant said: “I don’t have to take a drug or wear a device … it’s just a part of my body now that will be with me for the rest of my days, so that I’m thrilled with.” 

    Participants’ ability to adhere to the intervention over long periods of time is one of its potential advantages. 

    “Especially for people in their 30s, 40s, or 50s, osteoarthritis could mean decades of pain management before they’re recommended for a joint replacement,” said Uhrlich. “This intervention could help fill that large treatment gap.” 

    Before this intervention can be clinically deployed, the gait retraining process will need to be streamlined. The motion-capture technique used to make the original foot angle prescription is expensive and time-consuming; the researchers envision this intervention to eventually be prescribed in a physical therapy clinic and retraining can happen while people go for a walk around their neighborhood. 

    “We and others have developed technology that could be used to both personalize and deliver this intervention in a clinical setting using mobile sensors, like smartphone video and a ‘smart shoe,’” said Uhlrich. Future studies of this approach are needed before the intervention can be made widely available to the public.

    For more information

    Additional Stanford co-authors include Amy Silder, former associate director of the Human Performance Lab; Andrea Finlay, a staff statistician in the Ladd Lab; Feliks Kogan, assistant professor (research) of radiology in Stanford Medicine; and Garry Gold, professor of radiology in Stanford Medicine. Gary S. Beaupre of the Palo Alto VA is also a co-author. 

    Delp is also a professor of bioengineering, of mechanical engineering and, by courtesy, of orthopaedics in the Schools of Medicine and Engineering. He is also a member of Stanford Bio-X, the Maternal & Child Health Research Institute (MCHRI), and the Wu Tsai Neurosciences Institute. Gold is also a member of Bio-X, the Cardiovascular Institute, the Wu Tsai Human Performance Alliance, and the Wu Tsai Neurosciences Institute. Kogan is also a member of Bio-X and the Wu Tsai Human Performance Alliance. 

    The research was supported by fellowships from the National Science Foundation (DGE-114747) and the Stanford Office of the Vice Provost for Graduate Education, Merit Review Award I01 RX001811 from the United States Department of Veterans Affairs Rehabilitation Research and Development Service, and Award P2CHD101913 from the United States National Institutes of Health.

    Continue Reading

  • expert reaction to papers published in the Lancet Psychiatry Physical Health Commission – on physical health monitoring for people prescribed psychiatric medication and looking at lifestyle interventions in mental health care

    Two papers published in the Lancet Psychiatry Physical Health Commission look at monitoring the physical health of people prescribed psychiatric medication and lifestyle interventions in mental health care. 

     

    Comment on the paper on physical health monitoring for people prescribed psychiatric medication*:

    Dr Natalie Shoham, Senior Clinical Lecturer in the Unit for Psychological Medicine at the Centre for Psychiatry and Mental Health, QMUL, and honorary consultant psychiatrist, said:

    “The second report of the Lancet Commission provides an up-to-date, comprehensive and practical guide for clinicians on how to reduce the burden of side effects caused by psychotropic medications, based on a review of a wide range of evidence.  The report has direct real-world implications for healthcare provision, and potential to improve quality of life for many individuals prescribed antipsychotic medications.  The challenges inherent in ensuring that all people prescribed antipsychotics benefit from the recommendations must now be addressed.”

     

    Dr Paul Keedwell, Consultant Psychiatrist and Fellow of the Royal College of Psychiatrists, said:

    “The report is a well-meaning set of recommendations for improving the physical health outcomes of people prescribed medication for mental illness.  Although clients often benefit from medication from a mental health point of view, many psychotropic medications put on weight and contribute to the development of metabolic syndrome.

    “Feedback from service users was included in the report.  This was particularly valuable.  Most individuals receive advice on diet and exercise, and even have gym memberships subsidised by the health service, but they commonly struggle to enact these for two main reasons.

    “Firstly, many individuals suffer with treatment-resistant illness, including disabling depression and schizophrenia, where the symptoms deter them from exercising and planning/preparing healthy meals.

    “Secondly, many medications that individuals might need to stay well provide a barrier to exercise by inducing sedation and lethargy.  This is particularly true with antipsychotics like clozapine, which commonly induce weight gain.

    “Until more effective and better-tolerated medications are developed for mental illness more consideration should be given to the use of additional medications like metformin which can help with weight loss, even in the absence of diabetes.  Also, it seems to me that this is a population that would benefit greatly from access to GLP agonists if they have medication induced obesity, including Wegovy and Mounjaro.”

     

    Dr Prasad Nishtala, Reader in the Department of Life Sciences, University of Bath, said:

    “This report is a landmark in bringing together the best available evidence on preventing and managing the physical health side effects of psychiatric medication.  Cardiometabolic and neurological complications can shorten life expectancy, while sexual health problems may reduce treatment adherence. Together, these issues significantly affect the overall quality of life.  The Commission rightly emphasises proactive prevention, shared decision-making, and coordinated care, and adding a standardised psychotropic adverse event monitoring tool would further strengthen clinical monitoring.  Or even better, integrated digital tools that combine intervention tracking with proactive side-effect monitoring, particularly during the early stages of treatment, would help clinicians act quickly and consistently to protect patients’ physical health.”

     

    Comments on both papers:

    Dr Jo Howe, Research Associate for the RESOLVE study, Aston University, said:

    “These two reports offer an evidence-based roadmap for preventing and managing the physical health side-effects of psychotropic medication and embedding lifestyle interventions in mental health care.  They highlight practical measures such as early monitoring, shared decision making, integrating lifestyle interventions like physical activity and nutrition support, and the prophylactic use of metformin for high-risk prescriptions.  Our research on antipsychotic-induced weight gain reinforces the value of preventative care — acting early to anticipate risks and making interventions sustainable within routine practice.  Many services still need clear guidance on when and how to initiate metformin, and clarity over responsibility for physical health.  Too often, mental and physical health care are delivered in silos, meaning opportunities for prevention are missed.  These reports are rigorous and grounded in current evidence, but their real-world impact will depend on breaking down these silos, alongside workforce capacity, service redesign, and policy commitment.  If implemented well, they could help close the unacceptable 13–15 year life expectancy gap for people with severe mental illness.”

     

    Prof Ian Maidment, Professor of Clinical Pharmacy, and Associate Dean Research and Enterprise (Pharmacy), Aston University, said:

    “Life expectancy in people with mental illnesses such as schizophrenia is reduced by up to 20 years partly related to physical health issues; managing the physical health of people with mental illness has been an international priority for many years.  Many psychotropic medications cause physical health problems for people with mental illness, for example anti-psychotics are associated with significant weight gain potentially 30kg or more.  The commission has synthesised the evidence and produced clear recommendations for practice.  One key challenge is implementation of the recommendations into day-to-day routine clinical care.  Successful implementation will require a system wide approach working across primary, secondary and social care.  In summary, we desperately need to improve the physical healthcare in people with mental illnesses; implementation of the evidence is a vital next step.”

     

     

     

    *‘Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health Commission’ by Sean Halstead et al. was published in the Lancet Psychiatry at 23:30 UK time on Tuesday 12 August 2025. 

    DOI: 10.1016/S2215-0366(25)00162-2

    ‘Implementing lifestyle interventions in mental health care: third report of the Lancet Psychiatry Physical Health Commission’ by Scott B Teasdale et al. was published in the Lancet Psychiatry at 23:30 UK time on Tuesday 12 August 2025. 

     

     

     

    Declared interests

    Dr Natalie Shoham: “My COI is that one author was a subsidiary supervisor for my PhD.”

    Dr Paul Keedwell: “No conflicts of interest.”

    Dr Prasad Nishtala: “No COI to declare.”

    Dr Jo Howe: “I am a chartered psychologist and research consultant specialising in mental and physical health integration, including NIHR-funded work on antipsychotic-induced weight gain and preventative care pathways (https://doi.org/10.1111/obr.13962).  I have no relevant industry funding and no current advisory roles with pharmaceutical companies.”

    Prof Ian Maidment: “I’m an active researcher in this area, but don’t believe that this represents a Conflict of Interest.  See: Non-pharmacologicaL InterVEntions for Antipsychotic-Induced Weight Gain (RESOLVE) in People Living With Severe Mental Illness: A Realist Synthesis. Obesity Reviews. e13962, https://doi.org/10.1111/obr.13962.”

     

     

     

    Continue Reading